Zevra Therapeutics, Inc. (ZVRA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Zevra Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 5.95x | -3.66x | -5.04x | -5.91x | -30.31x | -3.49x |
| P/B Ratio | 3.20x | 9.72x | 3.75x | 2.11x | 2.04x | -0.67x |
| P/S Ratio | 4.65x | 16.34x | 8.46x | 15.58x | 9.05x | 3.36x |
| Profitability | ||||||
| Gross Margin | 84.5% | 68.6% | 89.3% | 97.8% | 92.8% | 90.2% |
| Operating Margin | -4.0% | -368.5% | -180.6% | -418.9% | 27.0% | -42.2% |
| Net Margin | 78.2% | -446.9% | -167.7% | -263.5% | -29.9% | -96.0% |
| EBITDA Margin | 92.7% | -323.6% | -158.6% | -251.2% | -27.5% | -40.9% |
| Liquidity | ||||||
| Current Ratio | 5.68x | 2.53x | 1.18x | 7.72x | 27.20x | 1.11x |
| Quick Ratio | 5.63x | 2.47x | 0.85x | 7.72x | 27.20x | 1.11x |
| Leverage | ||||||
| Debt/Equity | 0.41x | 1.52x | 0.71x | 0.25x | 0.01x | -1.06x |
YoY = year-over-year change. Source: FMP..